Air Liquide strengthens its Home Healthcare activity with an acquisition in Belgium and the Netherlands
April 09 2024 - 2:45AM
Business Wire
Regulatory News:
Air Liquide (Paris:AI) is continuing its
development with the acquisition of Homecare activities in Belgium
and the Netherlands. With this operation, the Group broadens its
presence and offer in these countries. Worldwide Air Liquide
already supports 2 million people at home living with a chronic
disease and has made Home Healthcare activities one of its
strategic development priorities.
The two entities acquired in Belgium and the Netherlands
support 10,000 patients living with respiratory insufficiency,
sleep apnea syndrome or requiring infusion or nutrition
treatments. With a turnover of more than €10 million in 2023,
they are supported by around fifty employees who have joined the
Air Liquide Group.
VitalAire, Air Liquide's international Home Healthcare brand, is
already present in Belgium, Luxembourg and the Netherlands. Drawing
on its medico-technical expertise, its experience in personalized
support for patients and in the development of associated digital
services, Air Liquide, through this acquisition, is
strengthening its presence and completing its infusion offer in
these two countries.
The geographic and therapeutic complementarity of the acquired
entities, combined with the professionalism and the operational
excellence of the Air Liquide Group's teams, will facilitate the
development of care plans adapted to patients' needs and
profiles.
Diana Schillag, member of Air Liquide's Executive
Committee in charge of Healthcare, Sustainable Development and
Procurement, stated: "We are delighted to strengthen our
position in those growing markets and to welcome these new patients
and employees to Air Liquide. As a major player in Home Healthcare
throughout the world, our ambition is to improve the quality of
life of patients to best meet their needs at the lowest cost to
society, thereby contributing to more efficient and sustainable
healthcare systems."
Air Liquide
Healthcare Air Liquide Healthcare is a world leader in
medical gases, home healthcare services and specialty ingredients.
Our 16,500 employees support 2 million chronic patients and provide
medical gases and related services to 20,000 hospitals and new care
facilities, as well as 140,000 healthcare professionals. Committed
to working alongside professionals and health institutions, our
patient-centered approach is based on the principles of Value-based
Healthcare, which aims to improve the benefits experienced by
patients, at the best cost to society, thus contributing to a more
efficient and virtuous system.
Air Liquide is a world leader in gases, technologies and
services for industry and healthcare. Present in 72 countries with
67,800 employees, the Group serves more than 4 million customers
and patients. Oxygen, nitrogen and hydrogen are essential small
molecules for life, matter and energy. They embody Air Liquide’s
scientific territory and have been at the core of the Group’s
activities since its creation in 1902.
Taking action today while preparing the future is at the heart
of Air Liquide’s strategy. With ADVANCE, its strategic plan for
2025, Air Liquide is targeting a global performance, combining
financial and extra-financial dimensions. Positioned on new
markets, the Group benefits from major assets such as its business
model combining resilience and strength, its ability to innovate
and its technological expertise. The Group develops solutions
contributing to climate and the energy transition—particularly with
hydrogen—and takes action to progress in areas of healthcare,
digital and high technologies.
Air Liquide’s revenue amounted to more than 27.5 billion euros
in 2023. Air Liquide is listed on the Euronext Paris stock exchange
(compartment A) and belongs to the CAC 40, CAC 40 ESG, EURO STOXX
50, FTSE4Good and DJSI Europe indexes.
www.airliquide.com Follow us Twitter
@airliquidegroup
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240408195214/en/
Corporate Communications media@airliquide.com
Investor Relations IRTeam@airliquide.com
C3 AI (NYSE:AI)
Historical Stock Chart
From Apr 2024 to May 2024
C3 AI (NYSE:AI)
Historical Stock Chart
From May 2023 to May 2024